AP1724A - Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination - Google Patents
Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccinationInfo
- Publication number
- AP1724A AP1724A AP2005003378A AP2005003378A AP1724A AP 1724 A AP1724 A AP 1724A AP 2005003378 A AP2005003378 A AP 2005003378A AP 2005003378 A AP2005003378 A AP 2005003378A AP 1724 A AP1724 A AP 1724A
- Authority
- AP
- ARIPO
- Prior art keywords
- freeze dried
- vibrio cholerae
- safety features
- dried form
- biological safety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20030039A CU23209A1 (es) | 2003-02-20 | 2003-02-20 | Candidatos vacunales vivos con indices mejorados de seguridad ambiental para inmunizar oralmente contra el colera |
CU20030084A CU23206A1 (es) | 2003-04-17 | 2003-04-17 | Formulaciones para liofilizacion de vacunas vivas atenuadas de vibrio cholerae mejoradas en su seguridad ambiental |
PCT/CU2004/000002 WO2004073736A1 (es) | 2003-02-20 | 2004-02-19 | Cepas atenuadas de vibrio cholerae y vacunas liofilizadas que las contienen |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2005003378A0 AP2005003378A0 (en) | 2005-09-30 |
AP1724A true AP1724A (en) | 2007-02-23 |
Family
ID=40203010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2005003378A AP1724A (en) | 2003-02-20 | 2004-02-19 | Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
Country Status (16)
Country | Link |
---|---|
US (1) | US7592171B2 (es) |
EP (1) | EP1614426B1 (es) |
JP (1) | JP4495143B2 (es) |
CN (1) | CN100569286C (es) |
AP (1) | AP1724A (es) |
AT (1) | ATE417625T1 (es) |
BR (1) | BRPI0407668A (es) |
CA (1) | CA2516581C (es) |
DE (1) | DE602004018478D1 (es) |
DK (1) | DK1614426T3 (es) |
EC (1) | ECSP055971A (es) |
ES (1) | ES2319527T3 (es) |
MX (1) | MXPA05008774A (es) |
OA (1) | OA13033A (es) |
RU (1) | RU2316587C2 (es) |
WO (1) | WO2004073736A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0325494D0 (en) * | 2003-10-31 | 2003-12-03 | Sbl Vaccin Ab | Expression system |
US20060233837A1 (en) * | 2005-04-19 | 2006-10-19 | Gomez Javier C | Vibrio cholerae vaccine candidates, the methods of their constructing and medicinal preparations derived thereof |
WO2008143782A1 (en) * | 2007-05-18 | 2008-11-27 | Medimmune, Llc | Preservation of bioactive materials by freeze dried foam |
CN101880640B (zh) * | 2010-02-09 | 2013-05-29 | 北京万特尔生物制药有限公司 | 肺炎克雷伯氏菌(甘露糖敏感血凝)菌毛株 |
CN101914463B (zh) * | 2010-02-09 | 2012-09-05 | 北京万特尔生物制药有限公司 | 普通变形菌(甘露糖敏感血凝)菌毛株 |
CU24188B1 (es) * | 2012-12-27 | 2016-07-29 | Ct De Ingeniería Genética Y Biotecnología | Composición vacunal contra el virus dengue |
WO2016113322A1 (en) * | 2015-01-14 | 2016-07-21 | Centre National De La Recherche Scientifique | Genetically modified vibrio cholerae strains and uses thereof |
CN111511394B (zh) * | 2017-07-12 | 2024-02-06 | 布里格姆妇女医院 | 具有益生菌特性的活减毒霍乱疫苗 |
CN110184241B (zh) * | 2019-05-14 | 2021-01-26 | 菲吉乐科(南京)生物科技有限公司 | 耐高温溶藻弧菌噬菌体及其组合物、试剂盒和应用 |
CN111004759B (zh) * | 2020-01-04 | 2023-04-07 | 广东环凯生物科技有限公司 | 一种霍乱弧菌的稳定剂及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999005548A1 (fr) * | 1997-07-25 | 1999-02-04 | Mitsubishi Rayon Co., Ltd. | Fibre optique de type a profil d'indice de refraction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9808922D0 (en) * | 1998-04-24 | 1998-06-24 | Cantab Pharmaceuticals Res Ltd | Virus preparations |
CU22847A1 (es) * | 1998-10-22 | 2003-04-28 | Cnic Ct Nac Investigaciones | Conservación de formulaciones vacunales de vibrio cholerae |
-
2004
- 2004-02-19 BR BRPI0407668-0A patent/BRPI0407668A/pt not_active Application Discontinuation
- 2004-02-19 ES ES04712469T patent/ES2319527T3/es not_active Expired - Lifetime
- 2004-02-19 OA OA1200500234A patent/OA13033A/en unknown
- 2004-02-19 WO PCT/CU2004/000002 patent/WO2004073736A1/es active Application Filing
- 2004-02-19 EP EP04712469A patent/EP1614426B1/en not_active Expired - Lifetime
- 2004-02-19 JP JP2006501454A patent/JP4495143B2/ja not_active Expired - Fee Related
- 2004-02-19 CN CNB2004800101011A patent/CN100569286C/zh not_active Expired - Fee Related
- 2004-02-19 RU RU2005125793/13A patent/RU2316587C2/ru active
- 2004-02-19 DE DE602004018478T patent/DE602004018478D1/de not_active Expired - Lifetime
- 2004-02-19 AT AT04712469T patent/ATE417625T1/de active
- 2004-02-19 US US10/546,410 patent/US7592171B2/en active Active
- 2004-02-19 DK DK04712469T patent/DK1614426T3/da active
- 2004-02-19 MX MXPA05008774A patent/MXPA05008774A/es active IP Right Grant
- 2004-02-19 AP AP2005003378A patent/AP1724A/xx active
- 2004-02-19 CA CA2516581A patent/CA2516581C/en not_active Expired - Fee Related
-
2005
- 2005-08-18 EC EC2005005971A patent/ECSP055971A/es unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999005548A1 (fr) * | 1997-07-25 | 1999-02-04 | Mitsubishi Rayon Co., Ltd. | Fibre optique de type a profil d'indice de refraction |
Non-Patent Citations (2)
Title |
---|
EHARA M. ET AL.: 'Characterization of filamentous phages of Vibrio cholerae O139 and O1' FEMS MICROBIOLOGY LETTERS vol. 154, no. 2, 15 September 1997, pages 293 - 301 * |
JOURAVLEVA E.A. ET AL.: 'The Vibrio cholerae mannose-sensitive hemagglutinin is the receptor for filamentous bacteriophage from V. cholerae O139' INFECTION AND IMMUNITY vol. 66, no. 6, June 1998, pages 2535 - 2539 * |
Also Published As
Publication number | Publication date |
---|---|
RU2005125793A (ru) | 2006-05-27 |
CN1780640A (zh) | 2006-05-31 |
JP2006518196A (ja) | 2006-08-10 |
DK1614426T3 (da) | 2009-04-06 |
CN100569286C (zh) | 2009-12-16 |
CA2516581C (en) | 2012-05-15 |
JP4495143B2 (ja) | 2010-06-30 |
BRPI0407668A (pt) | 2006-03-01 |
ECSP055971A (es) | 2006-01-16 |
AP2005003378A0 (en) | 2005-09-30 |
WO2004073736A1 (es) | 2004-09-02 |
US7592171B2 (en) | 2009-09-22 |
DE602004018478D1 (de) | 2009-01-29 |
EP1614426A1 (en) | 2006-01-11 |
ATE417625T1 (de) | 2009-01-15 |
MXPA05008774A (es) | 2006-02-22 |
EP1614426B1 (en) | 2008-12-17 |
US20070071775A1 (en) | 2007-03-29 |
RU2316587C2 (ru) | 2008-02-10 |
WO2004073736A8 (es) | 2005-11-17 |
ES2319527T3 (es) | 2009-05-08 |
CA2516581A1 (en) | 2004-09-02 |
OA13033A (en) | 2006-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL223141A0 (en) | Immunogenic composition for use in vaccination against staphylococcei | |
HK1127044A1 (en) | Process for the preparation of asenapine and intermediate products used in said process | |
EP1948810A4 (en) | COMPOSITION AND METHOD USING CHITOSAN FOR THE EFFICIENT ADMINISTRATION OF NUCLEIC ACIDS TO CELLS | |
IL210916A (en) | Clonidine and medicinal products containing it for the prevention or treatment of mucosal inflammation | |
PL2105129T3 (pl) | Szczepionki w kapsułkach do szczepienia doustnego i wzmocnienia dla ryb i innych zwierząt | |
GB2479679B (en) | Refuge chamber and method | |
SG2009050212A (en) | Severe acute respiratory syndrome dna vaccine compositions and methods of use | |
ZA200603065B (en) | The use of anti biotics as vaccine adjuvants | |
EP1663222A4 (en) | METHODS RELATING TO THE TREATMENT OF GIANCES | |
EP2083843A4 (en) | MULTIFUNCTIONAL SUPPORTS FOR THE ADMINISTRATION OF NUCLEIC ACIDS AND METHOD OF USE THEREOF | |
AP1724A (en) | Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination | |
IL204821A (en) | An in vitro method for obtaining activated cells displaying antigens used to prepare cancer vaccines | |
IL174325A0 (en) | Dna vaccine compositions and methods of use | |
ZA200901993B (en) | Novel neutralizing immunogen (NIMIV) of rhinovirus and its use for vaccine applicants | |
HK1125041A1 (en) | Pharmaceutical formulations comprising dextran with molecular weight of 1.0-100kda and processes for their preparation | |
ZA200607132B (en) | Method of vaccination against testicular BVDV infection | |
GB0619816D0 (en) | Novel interferon-alpha constructs for use in the treatment of cancer | |
EP1592409A4 (en) | USE OF EDIBLE ACIDITY IN QUICKLY DISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORMS | |
GB0423681D0 (en) | Vaccine and nucleic acids | |
EP1620126A4 (en) | PREVENTION OF DISEASES AND VACCINATION BEFORE THYMUS REACTIVATION | |
IL177276A0 (en) | Method for delivering drugs to tissue under microject propulsion | |
GB0401036D0 (en) | Improvements in or relating to vaccination | |
EP2061506A4 (en) | VACCINE COMPOSITION AND IMMUNIZATION METHOD | |
HK1096609A1 (en) | Pharmaceutical composition for treating gastric disease containing antiulcerent and mucosal protective agents | |
EP1799097A4 (en) | DIRECTED LIGHT METHOD FOR DETECTING AND FACILITATING A SUBSEQUENT EVALUATION OF ABNORMAL MUCOUS TISSUE |